NeuroThera’s Proprietary Cannabinoid-Enhanced Platform Targets Antibiotic Resistance Using Approved Antimicrobials TEL AVIV, ...
Farmers in the U.S. have grown cannabis since the 1600s — but policymakers are still figuring out how to regulate two famous ...
A German pharmaceutical company called Farmako just registered a patent for a process in which genetically modified tequila bacterium produce a range of biosynthetic cannabinoids — the stuff that you ...
Medical Marijuana, Inc. (OTC: MJNA) (the "Company") today announced a strategic alliance with AXIM Biotechnologies, Inc. (OTC ...
New Australian research is systematically investigating the anticonvulsant effects of a number of rare compounds in cannabis. A new study is reporting cannabigerolic acid (CBGA), informally known as ...
The legalization of cannabis has created many opportunities for researchers to study the compounds in the cannabinoid family and discover new uses for them. Demetrix, a synthetic biology company ...
In an exclusive interview with Benzinga, Dr. Shane Johnson, MD, senior vice president and general manager of BayMedica, sheds light on the company's innovative approach to cannabinoid production. With ...
While current data on medical cannabinoids in rheumatology is limited, findings suggest that adverse events (AEs) and drug interactions outweigh the benefits. When evaluating whether cannabinoids used ...
The most common cannabinoids are THC and CBD, but there are more than 100. Researchers are starting to study lesser-known cannabinoids like CBN, CBG, and THCV. Others are creating lab-grown ...
The global cannabis market is booming: it’s set to reach $146 billion by 2025. There is a rapidly growing demand for cannabinoids, the compounds found in the cannabis plant. The most well-known ...
Cannabinoids, naturally occurring compounds found in hemp plants, may have evolved to deter pests from chewing on them, according to new research that showed higher cannabinoid concentrations in hemp ...
AXIM Biotechnologies, Inc. (OTC: AXIM) (the "Company") today announced a strategic alliance with Medical Marijuana, Inc. (OTC: MJNA) intended to research and develop applications and uses for AXIM's ...